Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fox Chase Cancer Center
Primary Objective To compare the diagnostic yield of 22g and 19g EBUS transbronchial needle aspirate (TBNA)
Secondary Objectives
1. To compare the sample adequacy of 22g and 19g EBUS TBNA
2. To compare the sample quality of 22g and 19 g EBUS TBNA
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients undergoing EBUS TBNA for evaluation of lymphadenopathy, lung nodule or mass
Patients must have atypical lymph nodes. Atypical lymph nodes are characterized by \>10mm in short axis or lymph nodes 5-10mm in short axis with atypical features.
Age \> 18 years.
Patients must have platelets count \> 50,000
Ability to understand and willingness to sign a written informed consent and HIPAA consent document
WOCBP must agree not to get pregnant until the day of the procedure
You may not be if
Patients with uncorrectable coagulopathy will be excluded.
Patients with hemodynamic instability will be excluded
Patients with refractory hypoxemia will be excluded
Patients with therapeutic anticoagulant that cannot be held for 2 days before and 1 day after the procedure.
Patients who are unable to tolerate general anesthesia according to the anesthesiologist
Pregnant or breast feeding.
Clareo Health | Pilot Study to Investigate The Diagnostic Yield and Utility of 22g and 19g Endobronchial Ultrasound Transbronchial Needle Aspirate
